Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GMP Compliance Guidances Should Be Increased, Lilly’s Miner Says

Executive Summary

FDA needs to issue more guidances on GMP compliance topics, Lilly Corporate GMP Compliance Leader David Miner, PhD, said

You may also be interested in...



GMP Dispute Resolution Pilot May Build In Delay Before Form 483 Is Issued

FDA's GMP dispute resolution pilot could allow drug inspectors a "short post-inspection delay" prior to issuing a Form 483 manufacturing report

GMP Dispute Resolution Pilot May Build In Delay Before Form 483 Is Issued

FDA's GMP dispute resolution pilot could allow drug inspectors a "short post-inspection delay" prior to issuing a Form 483 manufacturing report

FDA GMP Plan Stresses Consistency; Systems Approach Ratified By Crawford

FDA will work with an outside consultant to help increase the consistency of pre-approval and post-approval manufacturing oversight

Related Content

UsernamePublicRestriction

Register

PS039705

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel